| Meta-analysis
finds cisplatin improves post-operative survival in patients with
non-small lung cancer.
ASCO 2008 meeting: Cetuximab
plus platinum chemotherapy agents effective treatment for lung
cancer.
Also
for head and neck cancers.
Resistance
to Cisplatin - due to copper transporter - National Institute
of General Medical Sciences
Cisplatin-Based
Chemotherapy Improves Survival in Non-Small Cell Lung Cancer -
National Cancer Institute
Meta-Analysis
Suggests Cisplatin Superior to Carboplatin for Advanced NSCLC
- NCI Clinical Trial result
Long-Term
Data Support Cisplatin-Based Chemoradiation for Cervical Cancer
- NCI Clinical Trial result
Cisplatin-Based
Chemotherapy Improves Survival in Non-Small Cell Lung Cancer
- Clinical trial result
Cisplatin-
versus carboplatin-based chemotherapy in first-line treatment
of advanced non-small-cell lung cancer
Antitumor
activity of the combination of synthetic retinoid ST1926 and cisplatin
in ovarian carcinoma models.
Other web resources
about cisplatin |
Cisplatin
How it Works